Hartford Funds Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.87M Sell
3,123
-91
-3% -$92.3K 0.25% 18
2025
Q4
$3.46M Buy
3,214
+1,373
+75% +$1.31M 0.28% 17
2025
Q3
$1.41M Buy
1,841
+37
+2% +$27.5K 0.12% 28
2025
Q2
$1.41M Buy
1,804
+2
+0.1% +$1.55K 0.12% 30
2025
Q1
$1.49M Buy
1,802
+340
+23% +$283K 0.13% 27
2024
Q4
$1.13M Buy
1,462
+44
+3% +$36.4K 0.1% 35
2024
Q3
$1.26M Buy
1,418
+55
+4% +$49.4K 0.12% 25
2024
Q2
$1.23M Buy
1,363
+61
+5% +$48.8K 0.12% 20
2024
Q1
$1.01M Sell
1,302
-190
-13% -$135K 0.1% 26
2023
Q4
$870K Sell
1,492
-195
-12% -$114K 0.09% 23
2023
Q3
$906K Buy
1,687
+92
+6% +$47.4K 0.1% 13
2023
Q2
$748K Sell
1,595
-25
-2% -$10.5K 0.08% 19
2023
Q1
$557K Sell
1,620
-4
-0.2% -$1.35K 0.06% 21
2022
Q4
$594K Buy
1,624
+8
+0.5% +$2.84K 0.06% 19
2022
Q3
$522K Buy
1,616
+421
+35% +$133K 0.06% 11
2022
Q2
$387K Buy
1,195
+134
+13% +$40.2K 0.04% 11
2022
Q1
$303K Buy
+1,061
New +$273K 0.03% 10

Other funds holding LLY

Hartford Funds Management's LLY Position: Q1 2026 in Review

Hartford Funds Management reduced its Eli Lilly (LLY) stake by 2.8% in Q1 2026, selling an estimated $92.3K and leaving 3,123 shares worth $2.87M. The position accounts for 0.25% of the portfolio, ranked #18.

Hartford Funds Management first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.46M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hartford Funds Management held 3,123 shares of Eli Lilly worth $2.87M as of Q1 2026.
  • Hartford Funds Management sold 91 Eli Lilly shares in Q1 2026, an estimated $92.3K.
  • Eli Lilly made up 0.25% of Hartford Funds Management's portfolio in Q1 2026, its #18 holding.
  • Hartford Funds Management first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
  • Hartford Funds Management's Eli Lilly position peaked at $3.46M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hartford Funds Management's 13F filing for Q1 2026, filed 4 May 2026.